| HOME >> BIOLOGY >> TECHNOLOGY |
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 129
Table 47: Spanish 11-Year Perspective for Anticoagulants by
Product Segment - Percentage Breakdown of Dollar Sales for
Oral Anticoagulants and Injectable Anticoagulants
(Unfractionated Heparin and Low Molecular Weight Heparin)
Markets for the Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 130
16f. REST OF EUROPE 131
Market Analysis 131
Table 48: Rest of Europe Recent Past, Current & Future
Analysis for Anticoagulants by Product Segment - Oral
Anticoagulants and Injectable Anticoagulants (Unfractionated
Heparin and Low Molecular Weight Heparin) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 131
Table 49: Rest of Europe Historic Review for Anticoagulants
by Product Segment - Oral Anticoagulants and Injectable
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006
(includes corresponding Graph/Chart) 132
Table 50: Rest of Europe 11-Year Perspective for
Anticoagulants by Product Segment - Percentage Breakdown of
Dollar Sales for Oral Anticoagulants and Injectable
Anticoagulants (Unfractionated Heparin and Low Molecular
Weight Heparin) Markets for the Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 133
17. REST OF WORLD 134
A.Market Analysis 134
Outlook 134
Anticoagulants Market in Australia 134
B.Market Analytics 135
Table 51: Rest of World Recent Past, Current &
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |